rs201162411
Variant summary
Our verdict is Uncertain significance. Variant got 1 ACMG points: 3P and 2B. PM1PP5BP4BS1_Supporting
The NM_001297.5(CNGB1):โc.2957A>Tโ(p.Asn986Ile) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.00118 in 1,614,166 control chromosomes in the GnomAD database, including 4 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Conflicting classifications of pathogenicity (no stars).
Frequency
Consequence
NM_001297.5 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Uncertain_significance. Variant got 1 ACMG points.
Transcripts
RefSeq
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
CNGB1 | ENST00000251102.13 | c.2957A>T | p.Asn986Ile | missense_variant | Exon 29 of 33 | 1 | NM_001297.5 | ENSP00000251102.8 | ||
CNGB1 | ENST00000564448.5 | c.2939A>T | p.Asn980Ile | missense_variant | Exon 29 of 33 | 1 | ENSP00000454633.1 | |||
CNGB1 | ENST00000565942.1 | c.2A>T | p.Asn1Ile | missense_variant | Exon 1 of 4 | 5 | ENSP00000455964.1 | |||
CNGB1 | ENST00000569643.1 | n.614A>T | non_coding_transcript_exon_variant | Exon 5 of 6 | 5 |
Frequencies
GnomAD3 genomes AF: 0.00107 AC: 163AN: 152178Hom.: 0 Cov.: 32
GnomAD3 exomes AF: 0.00114 AC: 285AN: 249524Hom.: 0 AF XY: 0.00103 AC XY: 139AN XY: 135380
GnomAD4 exome AF: 0.00119 AC: 1739AN: 1461870Hom.: 4 Cov.: 33 AF XY: 0.00109 AC XY: 791AN XY: 727234
GnomAD4 genome AF: 0.00107 AC: 163AN: 152296Hom.: 0 Cov.: 32 AF XY: 0.00128 AC XY: 95AN XY: 74476
ClinVar
Submissions by phenotype
Retinitis pigmentosa Pathogenic:6
The CNGB1 c.2957A>T (p.Asn986Ile) missense variant has been reported in two studies in which it is found in six unrelated individuals with an autosomal recessive form of retinitis pigmentosa, including in four in a homozygous state and in two in a compound heterozygous state (Simpson et al. 2011; Hull et al. 2017). Common phenotypes in these individuals included night blindness with an onset in infancy or childhood, loss of peripheral vision in adulthood, and based on a fundus exam, a majority of patients had optic disc pallor, retinal pigment epithelium atrophy, and intraretinal pigment migration. The two individuals with the variant in a compound heterozygous state also had affected siblings with the same variants, one affected sister in one family and an additional affected brother and sister in the second family (Hull et al. 2017). The p.Asn986Ile variant was absent from 720 control chromosomes (Simpson et al. 2011) and is reported at a frequency of 0.00652 in the European (Finnish) population of the Genome Aggregation Database. Based on the clinical evidence, the p.Asn986Ile variant is classified as pathogenic for an autosomal recessive form of retinitis pigmentosa. This variant was observed by ICSL as part of a predisposition screen in an ostensibly healthy population. -
- -
- -
The p.Asn986Ile variant in CNGB1 was identified in an individual with Retinitis pigmentosa, via a collaborative study between the Broad Institute's Center for Mendelian Genomics and the Pierce lab (https://oculargenomics.meei.harvard.edu/labs/pierce-lab/lab-members/). Through a review of available evidence we were able to apply the following criteria: PS4, PM3, PP1, PP3, PP5. Based on this evidence we have classified this variant as Likely Pathogenic. If you have any questions about the classification please reach out to the Pierce Lab. -
The p.Asn986Ile variant in CNGB1 has been reported in multiple individuals with retinitis pigmentosa, all of whom were homozygous or compound heterozygous with a second CNGB1 variant (Simpson 2011, PMID: 21147909; Abu-Safieh 2013, PMID: 23105016; Carss 2017, PMID: 28041643; Stone 2017, PMID: 28559085; Hull 2017, PMID: 28056120; Fuster-Garcia 2019, PMID: 31725169; Jespersgaad 2019, PMID: 30718709; Radojevic 2020, DOI: 10.1080/13816810.2020.1832532). This variant also segregated with disease in 6 affected individuals from 5 families (Hull, 2017, PMID: 28056120; Fuster-Garcia, 2019, PMID: 31725169; Radojevic, 2020, DOI: 10.1080/13816810.2020.1832532). This variant has been identified in 0.635% (159/25032) of European (Finnish) chromosomes by gnomAD (http://gnomad.broadinstitute.org) with no cases of homozygosity and a frequency low enough to be consistent with a recessive allele frequency for this gene. This variant has also been reported in ClinVar (Variation ID 166891). Computational prediction tools and conservation analyses support that this variant may impact the protein. In summary, this variant meets criteria to be classified as pathogenic for autosomal recessive retinitis pigmentosa. ACMG/AMP Criteria applied: PM3_VeryStrong, PP1_Strong, PP3. -
- -
not provided Pathogenic:4Uncertain:1
- -
- -
- -
This sequence change replaces asparagine, which is neutral and polar, with isoleucine, which is neutral and non-polar, at codon 986 of the CNGB1 protein (p.Asn986Ile). This variant is present in population databases (rs201162411, gnomAD 0.7%), and has an allele count higher than expected for a pathogenic variant. This missense change has been observed in individual(s) with retinitis pigmentosa (PMID: 21147909, 28041643, 28056120, 28559085, 29912909). In at least one individual the data is consistent with being in trans (on the opposite chromosome) from a pathogenic variant. It has also been observed to segregate with disease in related individuals. ClinVar contains an entry for this variant (Variation ID: 166891). Invitae Evidence Modeling of protein sequence and biophysical properties (such as structural, functional, and spatial information, amino acid conservation, physicochemical variation, residue mobility, and thermodynamic stability) indicates that this missense variant is expected to disrupt CNGB1 protein function with a positive predictive value of 80%. For these reasons, this variant has been classified as Pathogenic. -
In silico analysis supports that this missense variant has a deleterious effect on protein structure/function; This variant is associated with the following publications: (PMID: 23105016, 32483926, 32531858, 28056120, 26355662, 21147909, 29912909, 23977260, 24015210, 29068140, 28559085, 28041643, 30718709, 31725169, 31456290, 33465333, 34426522, 31570810, 33576794, 33847019, 32037395) -
Retinitis pigmentosa 45 Pathogenic:4Uncertain:1
This variant was determined to be pathogenic according to ACMG Guidelines, 2015 [PMID:25741868]. -
The CNGB1 c.2957A>T variant was identified in an individual with retinitis pigmentosa with a presumed recessive inheritance pattern. Through a review of available evidence we were able to apply the following criteria: PS4, PM3, PP1, PP3, PP5. Based on this evidence we have classified this variant as Likely Pathogenic. -
- -
- -
- -
Retinal dystrophy Pathogenic:2
- -
- -
CNGB1-related disorder Pathogenic:1
The CNGB1 c.2957A>T variant is predicted to result in the amino acid substitution p.Asn986Ile. This variant has been reported in the homozygous and compound heterozygous states in multiple individuals with retinitis pigmentosa (see for example, Table 2, Simpson et al. 2011. PubMed ID: 21147909; Table S1, Stone et al. 2017. PubMed ID: 28559085; Table S4, Jespersgaard et al. 2019. PubMed ID: 30718709). This variant is reported in 0.64% of alleles in individuals of European (Finnish) descent in gnomAD. This variant is interpreted as pathogenic. -
Autosomal recessive retinitis pigmentosa Pathogenic:1
- -
CNGB1-related retinopathy Pathogenic:1
- -
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at